Adaptive Biotechnologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. And thank you for joining us. With us, we're pleased to have the Adaptive team today, and we have Chad Robins, CEO.
Questions & Answers
To start, Chad, thanks for joining us. And maybe just to level set everyone, could you discuss the long-term vision for Adaptive? What do you think the portfolio will look like 2 years, 5 years, 10 years from now? And how much of a role will be therapeutics vertical play as a part of this business?
Sure. First, Salveen, thanks for having me back at the Goldman Sachs Healthcare Conference. I appreciate it. So I want to start the answer to this question with the premise that our immune system, it fundamentally does 2 things: it detects disease and it treats
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
